Navigation Links
Hissey Kientz, LLP Warns Duragesic Patch Users About Potential Health Risks of Fentanyl Overdose
Date:12/13/2008

Hissey Kientz, LLP wishes to alert patients of the serious and potentially fatal health risks they may face from using the Duragesic (fentanyl) pain patch. Patients who are directly exposed to the gel inside the patch, or who received an excessive fentanyl dose because of other factors, may develop respiratory depression or other serious and potentially fatal side effects.

Austin, Texas (PRWEB) December 13, 2008 — The law firm of Hissey Kientz, LLP wishes to alert patients who use the Duragesic (fentanyl) pain patch of the serious and potentially fatal health risks they may face from the use of this powerful painkilling drug.

The Duragesic pain patch was first approved by the Food and Drug Administration in August 1990 to treat certain patients with chronic pain. The Duragesic-brand patch is manufactured by Alza Corp., which is owned by Johnson & Johnson. Generic versions of the pain patch—marketed under the name fentanyl—are also sold by several other companies.

The pain patch contains an extremely potent pain medication known as fentanyl, which is about 80 times as strong as morphine, according to the U.S. Drug Enforcement Administration. Federal and state health authorities have reported hundreds of cases of hospitalization or death that have been linked to fentanyl overdoses.

Millions of fentanyl or Duragesic patches have been recalled since 2005 due to manufacturing problems that could lead to a fatal overdose. Because some of these recalled patches may have been cut or improperly sealed, they could cause patients or other individuals who handle the pain patch to be directly exposed to the fentanyl gel contained in its drug reservoir. Due to the high potency of fentanyl, direct exposure can lead to a fatal overdose or other serious injuries.

“Fentanyl is a very powerful drug. A number of patients have died after problems with the pain patch caused the gel inside to come in direct contact with their skin,” says attorney Michael Hissey of Hissey Kientz, LLP. “Patients who use Duragesic or generic fentanyl patches need to be aware of the health dangers that could result from the use of these products.”

In June 2005, the manufacturer of the Duragesic patch added a “black-box warning” to the product’s label to alert doctors and patients of the risk of severe and potentially deadly side effects linked to the pain patch, including “life-threatening hypoventilation” and “fatal respiratory depression.” The label also warned that patches which are cut or damaged should not be used because of the risk for fatal overdose that they pose.

The Duragesic black-box warning was updated in February 2008 to include additional information about the health risks associated with the patch. The new warning advised patients to avoid exposing the patch to external heat sources after it is placed on the skin. Because heat can increase the rate at which the medication in a transdermal patch is absorbed into the body, patients could receive an increased dose of fentanyl, which may lead to an overdose. According to the updated warning, patients who use the Duragesic or fentanyl patch should avoid heating pads, electric blankets, sunbathing, hot baths and other activities or items that create heat.

Many patients who were harmed after using the Duragesic or fentanyl patch have filed lawsuits against the manufacturers of these products. In November 2008, a jury awarded $16.5 million to the family of a Chicago woman who died of a fentanyl overdose while wearing the Duragesic patch (Case No. 04L5351; Cook County, Illinois, Circuit Court).

About Hissey Kientz, LLP
Hissey Kientz, LLP is currently accepting cases involving individuals who may have been injured as a result of a fentanyl or Duragesic overdose. Hissey Kientz, LLP also represents those who contracted mesothelioma or lung cancer as a result of asbestos exposure, and those injured by the Ortho Evra patch, Digitek, Trasylol, the Composix Kugel mesh patch, PPH related to Fen-Phen, gadolinium MRI contrast dyes or other defective drugs and devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP (www.hkllp.com) or call toll-free at (866) 275-4454.

###

Read the full story at http://www.prweb.com/releases/2008/12/prweb1744344.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
2. Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
3. FDA Warns of Codeine Risk for Some Nursing Mothers
4. PA Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Perry County Dairy
5. Research warns that human papillomavirus might cause bladder cancer
6. New research warns of the lack of specialization when judging individuals with mental disorders
7. Coalition of Caregivers Warns Congress of Danger to Oldest U.S. Seniors if Medicare Slashed
8. Health Department Warns Consumers of Home-Canned Soup Linked to Potter County Restaurant
9. FDA Warns Against Bio-Identical Hormone Therapy
10. Cold Meds Not Safe for Kids Under 2, FDA Warns
11. FDA Warns Clot Risk Higher in Birth Control Patch Than Pill
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hissey Kientz, LLP Warns Duragesic Patch Users About Potential Health Risks of Fentanyl Overdose
(Date:12/8/2016)... ... December 08, 2016 , ... ... announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input to ... Medical Informatics . , Results of the comparative usability study demonstrate that a ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... its innovative Unified Instance Manager architecture, meeting the needs of multichannel growth ... optimizes the unattended auto-dialing system without agents, Presence Robodialer, provides greater operational ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... California Senate ... medical payments per workers’ compensation claim in 2013 and 2014, according to CompScope™ ... Research Institute (WCRI) . , According to the study, medical payments per claim in ...
(Date:12/8/2016)... ... December 08, 2016 , ... Dickinson Insurance and ... headquartered in Little Rock, has initiated a charity drive to provide support and ... to End Senior Hunger, Arkansas ranks first in senior hunger statewide, third in ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Economic growth in the United ... and supply management executives in their December 2016 Semiannual ... economic recovery that began in mid-2009, as indicated in ... ® . The manufacturing sector is optimistic about ... 16 manufacturing industries, and the non-manufacturing sector indicates that ...
(Date:12/8/2016)... According to a new market research report "Wearable Medical Devices Market ... Use (Sports, Fitness, RPM), Type (Smart watch, Patch), Distribution Channel (Pharmacy, Hypermarket) ... of value, is projected to reach 12.14 Billion by 2021 from USD ... period. Continue Reading ... ...
(Date:12/8/2016)... Calif. , Dec. 8, 2016  Agenovir ... to develop novel antiviral therapeutics, today announced that ... chief executive officer and a member of the ... incredibly experienced executive with a deep background in ... Quake, D.Phil., founder of Agenovir, co-president of Chan ...
Breaking Medicine Technology: